U.S. Markets open in 3 hrs 47 mins
  • S&P Futures

    3,654.75
    -5.75 (-0.16%)
     
  • Dow Futures

    29,717.00
    -87.00 (-0.29%)
     
  • Nasdaq Futures

    12,436.75
    -15.50 (-0.12%)
     
  • Russell 2000 Futures

    1,832.10
    -3.40 (-0.19%)
     
  • Crude Oil

    44.49
    -0.06 (-0.13%)
     
  • Gold

    1,833.60
    +14.70 (+0.81%)
     
  • Silver

    24.36
    +0.27 (+1.12%)
     
  • EUR/USD

    1.2055
    -0.0023 (-0.1929%)
     
  • 10-Yr Bond

    0.9340
    0.0000 (0.00%)
     
  • Vix

    20.90
    +0.33 (+1.60%)
     
  • GBP/USD

    1.3355
    -0.0068 (-0.5035%)
     
  • USD/JPY

    104.7110
    +0.3950 (+0.3787%)
     
  • BTC-USD

    19,131.78
    -39.96 (-0.21%)
     
  • CMC Crypto 200

    375.17
    -4.69 (-1.24%)
     
  • FTSE 100

    6,393.13
    +8.40 (+0.13%)
     
  • Nikkei 225

    26,800.98
    +13.44 (+0.05%)
     

Collegium Pharmaceutical: 1Q Earnings Snapshot

STOUGHTON, Mass. (AP) _ Collegium Pharmaceutical Inc. (COLL) on Wednesday reported a loss of $9.7 million in its first quarter.

The Stoughton, Massachusetts-based company said it had a loss of 29 cents per share. Losses, adjusted for stock option expense and non-recurring costs, were 5 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.

The specialty pharmaceutical company posted revenue of $74.5 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $70.1 million.

Collegium Pharmaceutical shares have fallen 18% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $14.05, a fall of 39% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL